THAP1 and Parkinson disease: Furthermore, DBS may have a differential effect for certain phenotypic manifestations (e.g., improvement in dystonia greater than parkinsonism for DYT/PARK-TAF1 or limited improvement in speech and swallowing in DYT-THAP1).